1.5. Analysis.
Comparison 1: Ivermectin compared to placebo or standard of care for people with moderate‐to‐severe COVID‐19 treated in the inpatient setting, Outcome 5: Any adverse events within 28 days (primary analysis)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.